Boryung Pharm (003850) — Cash Flow-to-Debt Ratio
Boryung Pharm (003850) has a Cash Flow-to-Debt Ratio of 0.09x as of September 2025, meaning its operating cash flow of ₩48.95 Billion could theoretically repay 0% of its total liabilities (₩537.67 Billion) in one year. Explore 003850 long-term asset investment ratio to see how much of total assets are deployed in long-term investments.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Boryung Pharm Cash Flow-to-Debt Ratio (2009–2024)
Historical debt coverage capacity for Boryung Pharm across 13 annual periods. Also explore 003850 total assets for the complete picture of this company's asset base.
Annual Cash Flow-to-Debt Ratio for Boryung Pharm (2009–2024)
Year-by-year debt coverage analysis for Boryung Pharm. For market capitalisation and broader financial context, see Boryung Pharm stock valuation.
| Year | CF-to-Debt Ratio | Operating CF (KRW) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2024 | 0.21x | ₩80.56 Billion | ₩379.58 Billion | ▲ +84.1% |
| 2023 | 0.12x | ₩42.22 Billion | ₩366.26 Billion | ▲ +55.8% |
| 2022 | 0.07x | ₩27.81 Billion | ₩375.97 Billion | ▼ -56.4% |
| 2021 | 0.17x | ₩60.17 Billion | ₩354.33 Billion | ▲ +16.8% |
| 2020 | 0.15x | ₩44.74 Billion | ₩307.71 Billion | ▼ -30.5% |
| 2019 | 0.21x | ₩47.00 Billion | ₩224.68 Billion | ▲ +4.2% |
| 2018 | 0.20x | ₩38.91 Billion | ₩193.91 Billion | ▲ +224.6% |
| 2017 | -0.16x | ₩-24.61 Billion | ₩152.86 Billion | ▼ -448.3% |
| 2016 | 0.05x | ₩9.36 Billion | ₩202.55 Billion | ▼ -68.0% |
| 2012 | 0.14x | ₩18.38 Billion | ₩127.21 Billion | ▲ +95.7% |
| 2011 | 0.07x | ₩9.19 Billion | ₩124.42 Billion | ▼ -66.5% |
| 2010 | 0.22x | ₩24.12 Billion | ₩109.45 Billion | ▲ +223.6% |
| 2009 | 0.07x | ₩3.59 Billion | ₩52.77 Billion | — |